Genesys wins a ₹283 Cr World Bank-funded Ahmedabad digital-twin contract — 86% of FY26 revenue in one order

On Thursday, September 24, Genesys International told the exchanges it has won a ₹283 crore, World Bank-funded contract to build a Geographic Information System (GIS) 3D digital map platform of Ahmedabad — a project the company describes as one of India's largest digital-twin and spatial-intelligence contracts. The press release reached the exchange at 10:07 IST, during the session; the stock closed the day at ₹283.18, up 0.7%, on volume roughly three times the prior session. A detailed Regulation 30 disclosure on the same order followed at 17:02 IST, after the close — so any further reaction to the annexure belongs to the next session, beyond this report's price data.

The scope described in the press release is unusually physical for an IT-services order. An elevation model will be developed using orthophotography, supported by 40 primary and 200 secondary survey control points. A key component is underground: existing water supply, sewerage, stormwater drainage and cable networks will be surveyed and mapped, including location and depth, and integrated into a central GIS database that municipal departments can share. The company says it will deploy its own constellation of sensors for the survey work, and frames the project as part of a city-scale digital-twin portfolio it has been building.

How big is ₹283 Cr for Genesys? Against the pack's stated share count of 4.18 crore shares (per the June 30 shareholding pattern) and the ₹283.18 close, market capitalisation is about ₹1,183 Cr — the order is roughly 24% of market cap. That figure predates the current share base: on August 24 the company allotted a further 2,50,74,226 rights shares, taking paid-up capital to roughly 6.69 crore shares, which would lower the order-to-market-cap ratio meaningfully once the enlarged base is reflected. Either way, this is a material order for a company of this size — with the caveat that delivery runs across roughly seven-and-a-half years including the O&M phase, so the annual revenue contribution will be a fraction of the headline.

The order did not move the stock much — because the stock had already moved. From the August 24 close of ₹178.55 to September 24's ₹283.18 is +58.6% in a month. The leg up came in bursts: +20.0% on August 25 and +15.0% on August 26 on 18.3 million shares — heavy enough that BSE and NSE wrote to the company on August 27 seeking clarification on the price movement. Genesys replied on August 28 that it had not received any formal contract award and pointed to a Gujarat Samachar article of August 24 reporting that Ahmedabad Municipal Corporation had awarded it a roughly ₹240 crore 3D GIS contract — the same project confirmed on September 24 — as the likely source of the speculation. A second burst came September 8 (+20.0%) and September 10 (+9.2%). The bulk-deal prints show same-day buy-and-sell round trips by QE Securities and Junomoneta Finsol on both September 8 and September 10, with HRTI additionally round-tripping on September 10 — net flat, which reads as trading churn rather than new positions being built. The September 11 close of ₹307.81 is the highest in this 60-session window; at ₹283.18 the stock is 32.2% below its adjusted 52-week high of ₹417.4 and 109.6% above the May low of ₹135.1.

FY26 added up to ₹327.8 Cr of consolidated revenue and ₹32.8 Cr of net profit, with a strong fourth quarter (₹104.2 Cr revenue, ₹12.7 Cr profit). Q1 FY27, filed on August 14, showed revenue of ₹81.4 Cr — up 14.8% year-on-year — but net profit of ₹5.3 Cr, down 24.3% from ₹7.0 Cr a year earlier. Interest expense has run at roughly ₹3.1 Cr a quarter through the period. The quarter-to-quarter swings in margin and profit are wide, which is one reason a single ₹283 Cr order changes the forward picture more for this company than it would for a larger one — and also why the undisclosed revenue-recognition schedule matters.

1. 31 Jul

   Rights Issue Committee files the Letter of Offer and fixes Aug 6 as the record date for the rights issue approved by the board on Jun 26.

2. 14 Aug

   Board approves Q1 FY27 results and a leadership rejig: Nikhil Alulkar appointed CEO (previously Head – India Business and Sr. VP at Tech Mahindra, per the Aug 17 press release), Aniruddha Roy re-designated Chief Innovation Officer, and Dhiman Basu Ray's appointment — announced as CTO in an Aug 27 press release.

3. 24 Aug

   Board allots 2,50,74,226 rights shares at ₹50 (₹5 face value + ₹45 premium) — roughly ₹125.4 Cr of fresh equity, computed from the allotment filing. The next session closed +20.0%.

4. 28 Aug

   Company replies to BSE and NSE letters (dated Aug 27) seeking clarification on the significant price movement, stating it has been in compliance with Regulation 30 disclosure requirements.

5. 2 Sept

   Board approves the appointment of G. K. Choksi & Co. as statutory auditors for a first term of five years, subject to shareholder approval; the meeting was also convened to consider the Genesys Employee Stock Option Scheme 2026.

6. 24 Sept

   ₹283 Cr Ahmedabad contract announced — press release at 10:07 IST, detailed Regulation 30 disclosure at 17:02 IST, after the close.

7. 30 Sept

   44th AGM scheduled, via video conferencing.

The two months before the order were a re-tooling: a new CEO from Tech Mahindra, a new CTO, a re-designated innovation chief, a new auditor proposed, and fresh capital — roughly ₹125.4 Cr from the rights issue on top of an earlier QIP whose proceeds are still under monitoring (CARE Ratings filed the monitoring agency report for the June quarter on August 14). Promoter holding stood at 31.50% in both the March and June shareholding patterns, both of which predate the rights allotment. The Ahmedabad order lands on that rebuilt base; whether the new leadership converts a headline win into reported revenue is now the measurable question.